These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20885070)

  • 21. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Proposal for the Optimal Management Target for Serum Non-High-Density Lipoprotein Cholesterol Level in Low-Risk Japanese Workers.
    Saiki Y; Otsuka T; Kato K; Kawada T
    J Atheroscler Thromb; 2016; 23(4):422-30. PubMed ID: 26875520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.
    Wang KF; Chang CC; Wang KL; Wu CH; Chen LC; Lu TM; Lin SJ; Chiang CE
    J Chin Med Assoc; 2014 Feb; 77(2):61-7. PubMed ID: 24332414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels ＜400 mg/dL.
    Moriyama K; Takahashi E
    J Atheroscler Thromb; 2016 Sep; 23(9):1126-37. PubMed ID: 27001003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
    Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
    Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.
    Okamura T; Kokubo Y; Watanabe M; Higashiyama A; Miyamoto Y; Yoshimasa Y; Okayama A
    Atherosclerosis; 2009 Apr; 203(2):587-92. PubMed ID: 18783774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Japan Society of Clinical Chemistry reference method and CDC method for HDL and LDL cholesterol measurements using fresh sera.
    Kayamori Y; Nakamura M; Kishi K; Miida T; Nishimura K; Okamura T; Hirayama S; Ohmura H; Yoshida H; Ai M; Tanaka A; Sumino H; Murakami M; Inoue I; Teramoto T; Yokoyama S
    Pract Lab Med; 2021 May; 25():e00228. PubMed ID: 34095414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement.
    Contois JH; Warnick GR; Sniderman AD
    J Clin Lipidol; 2011; 5(4):264-72. PubMed ID: 21784371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of lipid and lipoprotein measurements in community laboratories.
    Watson JE; Evans RW; Germanowski J; Caggiula AW; Olson MB; Hauth BA
    Arch Pathol Lab Med; 1997 Feb; 121(2):105-9. PubMed ID: 9126034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a homogeneous assay for measuring LDL-cholesterol in hyperlipidemic serum specimens.
    Yamashita S; Nakamura M; Koizumi H; Oku H; Sandoval JC; Tsubakio-Yamamoto K; Kawase M; Masuda D; Koseki M; Matsuura F; Shimomura I; Nishida M; Ishigami M
    J Atheroscler Thromb; 2008 Apr; 15(2):82-6. PubMed ID: 18385537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements.
    Myers GL; Kimberly MM; Waymack PP; Smith SJ; Cooper GR; Sampson EJ
    Clin Chem; 2000 Nov; 46(11):1762-72. PubMed ID: 11067811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre analysis of four low-density lipoprotein cholesterol direct assays in samples with extreme high-density lipoprotein cholesterol concentrations.
    Timón-Zapata J; Laserna-Mendieta EJ; Sáenz-Mateos LF; Ruiz-Trujillo L; Arpa-Fernández A; Palomino-Muñoz TJ; Loeches-Jiménez MP; Gómez-Serranillos M
    Clin Chim Acta; 2014 Mar; 430():71-6. PubMed ID: 24418620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.